Chronic Obstructive Pulmonary Disease
Sep 06, 2016
AstraZeneca’s new Asthma Drug Aces Phase III trial
AstraZeneca has got good results in the clinical trial for its next-generation asthma medication and could be available to patients by the end of next year. The drug, Benralizumab, is a new biological treatment for people with severe asthma, and works by targeting eosinophils that cause inflammation in the lungs of ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
